A detailed history of Jpmorgan Chase & CO transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 612,672 shares of IDXX stock, worth $255 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
612,672
Previous 768,455 20.27%
Holding current value
$255 Million
Previous $374 Million 17.36%
% of portfolio
0.03%
Previous 0.03%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024

SELL
$455.08 - $517.19 $70.9 Million - $80.6 Million
-155,783 Reduced 20.27%
612,672 $309 Million
Q3 2024

Nov 08, 2024

SELL
$455.08 - $517.19 $73.8 Million - $83.9 Million
-162,243 Reduced 21.45%
594,000 $300 Million
Q2 2024

Dec 26, 2024

BUY
$468.04 - $548.53 $81.7 Million - $95.7 Million
174,455 Added 29.37%
768,455 $374 Million
Q2 2024

Aug 12, 2024

SELL
$468.04 - $548.53 $9.84 Million - $11.5 Million
-21,015 Reduced 2.7%
756,243 $368 Million
Q1 2024

Dec 26, 2024

BUY
$515.08 - $576.87 $101 Million - $113 Million
195,470 Added 32.91%
789,470 $426 Million
Q1 2024

May 10, 2024

SELL
$515.08 - $576.87 $42.9 Million - $48 Million
-83,221 Reduced 9.67%
777,258 $420 Million
Q4 2023

Dec 26, 2024

BUY
$391.37 - $557.56 $109 Million - $155 Million
278,691 Added 46.92%
872,691 $484 Million
Q4 2023

Feb 12, 2024

BUY
$391.37 - $557.56 $23.2 Million - $33 Million
59,205 Added 7.39%
860,479 $478 Million
Q3 2023

Nov 14, 2023

BUY
$432.42 - $556.67 $28.4 Million - $36.6 Million
65,760 Added 8.94%
801,274 $350 Million
Q2 2023

Aug 11, 2023

BUY
$450.7 - $503.61 $64.6 Million - $72.1 Million
143,261 Added 24.19%
735,514 $369 Million
Q1 2023

May 18, 2023

BUY
$406.01 - $514.59 $15.8 Million - $20 Million
38,960 Added 7.04%
592,253 $296 Million
Q1 2023

May 11, 2023

BUY
$406.01 - $514.59 $10.1 Million - $12.8 Million
24,897 Added 4.71%
553,293 $277 Million
Q4 2022

Feb 13, 2023

BUY
$324.64 - $441.27 $38.9 Million - $52.8 Million
119,729 Added 29.3%
528,396 $216 Million
Q3 2022

Nov 14, 2022

SELL
$325.8 - $407.78 $7.88 Million - $9.87 Million
-24,195 Reduced 5.59%
408,667 $133 Million
Q2 2022

Aug 11, 2022

BUY
$327.37 - $553.44 $16.7 Million - $28.2 Million
50,869 Added 13.32%
432,862 $152 Million
Q1 2022

May 11, 2022

BUY
$466.52 - $631.01 $58.4 Million - $78.9 Million
125,091 Added 48.69%
381,993 $209 Million
Q4 2021

Feb 10, 2022

BUY
$586.54 - $666.48 $4.44 Million - $5.05 Million
7,575 Added 3.04%
256,902 $169 Million
Q3 2021

Nov 12, 2021

BUY
$621.9 - $705.76 $155 Million - $176 Million
249,327 New
249,327 $155 Million

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $34.6B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.